Indication
Fallopian Tube Serous Adenocarcinoma
2 clinical trials
3 products
2 drugs
Clinical trial
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or PeritoneumStatus: Recruiting, Estimated PCD: 2027-02-01
Product
CarboplatinProduct
LetrozoleDrug
TiragolumabClinical trial
A Phase 1 Study of PARP Inhibitor Olaparib and HSP90 Inhibitor AT13387 for Treatment of Advanced Solid Tumors With Expansion in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, Peritoneal Cancer or Recurrent Triple-Negative Breast CancerStatus: Completed, Estimated PCD: 2020-07-29
Drug
olaparibProduct
Onalespib